Moreover, taking advantage of GSTT1 Ab early appearance, institutions that implement protocol biopsy programs could gain clinical advantage by analyzing intragraft GSTT1 Abs
Doses greater than 0.4 mg/day should be avoided until the diagnosis of pernicious anemia is ruled out
Everything after that has been smooth sailing
Follow these detailed steps for a successful and safe injection process
*Correspondence: Alessandra Puddu, [email protected] These authors have contributed equally to this work This article was submitted to Gut Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
His team follows up regularly, providing reassurance and education during this initial transition phase